Get started
Author

Michel Janssens

Observed names: Janssens, Michel, M Janssens, MICHEL JANSSENS, Michel H. Janssens
Observed institutions: Médecins Sans Frontières, GlaxoSmithKline (Belgium), GlaxoSmithKline (Italy), Médecins Sans Frontières, Médecins Sans Frontières, University of Virginia
ORCID: 0000-0002-8800-9071
Observed ORCID: 0000-0002-8800-9071
OpenAlex ID: A5040449126
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
2008 · Pierre Vandepapelière, Yves Horsmans, et al. · Vaccine · 218
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
2017 · Wivine Burny, Andrea Callegaro, et al. · Frontiers in Immunology · 145
PDF
Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial
2016 · Geert Leroux-Roels, Arnaud Marchant, et al. · Clinical Immunology · 112
PDF
Intranasal pirodavir (R77,975) treatment of rhinovirus colds
1995 · F G Hayden, G J Hipskind, et al. · Antimicrobial Agents and Chemotherapy · 104
Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria
2011 · Ally Olotu, Philippe Moris, et al. · PLoS ONE · 96
PDF
A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
2013 · Jaime Montoya, Juan Antonio Solon, et al. · Journal of Clinical Immunology · 93
PDF
Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells
2011 · Joanne M. Lumsden, Robert J. Schwenk, et al. · PLoS ONE · 85
PDF
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
2010 · Isabel Leroux-Roels, Marguerite Koutsoukos, et al. · Vaccine · 76
T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
2011 · Daniel Ansong, Kwaku P. Asante, et al. · PLoS ONE · 66
PDF
An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers
2011 · Eva Van Braeckel, Patricia Bourguignon, et al. · Clinical Infectious Diseases · 62
PDF
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
2021 · Sonia Budroni, Francesca Buricchi, et al. · npj Vaccines · 59
PDF
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults
2019 · Paola Cicconi, Claire Jones, et al. · Clinical Infectious Diseases · 56
PDF
Measles outbreak in a refugee settlement in Calais, France: January to February 2016
2016 · G Jones, S Haeghebaert, et al. · Eurosurveillance · 56
PDF
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination
2014 · Geert Leroux-Roels, Pascale Van Belle, et al. · Vaccine · 48
PDF
Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D
2011 · Selidji T. Agnandji, Rolf Fendel, et al. · PLoS ONE · 47
PDF
Impact and Lessons Learned from Mass Drug Administrations of Malaria Chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014
2016 · Anna Kuehne, Amanda Tiffany, et al. · PLoS ONE · 45
PDF
Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles–mumps–rubella–varicella vaccine to children aged 11–21 months
2010 · Markus Knuf, Fred Zepp, et al. · European Journal of Pediatrics · 36
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: A randomised placebo-controlled study
2013 · Thomas Harrer, Andreas Plettenberg, et al. · Vaccine · 28
Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients
2014 · Patricia Bourguignon, Frédéric Clément, et al. · Journal of Immunological Methods · 25
Induction of Strong HIV-1–Specific CD4+ T-Cell Responses Using an HIV-1 gp120/NefTat Vaccine Adjuvanted With AS02A in Antiretroviral-Treated HIV-1–Infected Individuals
2011 · Mathias Lichterfeld, Rajesh T. Gandhi, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 20
Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium
2022 · Sarah Begue, Gwenn Waerlop, et al. · Frontiers in Immunology · 17
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine
2019 · Nicolas Folschweiller, Ulrich Behre, et al. · The Journal of Infectious Diseases · 16
PDF
Immunogenicity and Safety of a Booster Dose of an Investigational Adjuvanted Polyprotein HIV-1 Vaccine in Healthy Adults and Effect of Administration of Chloroquine
2014 · Geert Leroux-Roels, Patricia Bourguignon, et al. · Clinical and Vaccine Immunology · 15
PDF
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
2023 · Bruno Salaun, Jonathan De Smedt, et al. · Frontiers in Immunology · 13
PDF
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols
2023 · Gwenn Waerlop, Geert Leroux-Roels, et al. · Journal of Immunological Methods · 12
Works count: 38
Citation count: 1,596
H-index: 20
I10-index: 25
Year
Topic
Type